News

FDA Panel: No Benefit in Consumer Antibacterials


 

CTFA had previously asked the FDA to lower the threshold for approval of consumer antibacterial products. That request was not recommended by the panel at a meeting in March 2005. At that meeting, the panel voted unanimously to recommend retention of the standards for bacteria reduction in antibacterial and antiseptic products for nonconsumer products.

The FDA usually follows the recommendations of its advisory panels but is not obligated to do so. Final review of these products is to be concluded by 2007.

When antibacterial soap is compared with soap and water, no decrease in disease incidence or severity has been found.

Pages

Recommended Reading

Maximizing Vaccinations At 18-Month Visit Urged
MDedge Family Medicine
Childhood Hepatitis A Down, But Less So Among Hispanics
MDedge Family Medicine
Survey Highlights Parents' Opinions About Childhood Immunization
MDedge Family Medicine
Five in Minnesota Test Positive for Poliovirus
MDedge Family Medicine
Increase in Drug-Resistant Flu Called 'Alarming'
MDedge Family Medicine
Prescribe Fluoroquinolones With Care in CAP
MDedge Family Medicine
Activated Protein C Seen as Underused in Sepsis, Pneumonia
MDedge Family Medicine
Group A Strep Is Behind Most Uncomplicated Cellulitis Cases
MDedge Family Medicine
Rapid Test Called Not Yet Reliable for Strep Diagnosis
MDedge Family Medicine
Clinical Capsules
MDedge Family Medicine